Cargando…

Do we need to demonstrate amyloid in tissue for hereditary ATTR amyloidosis ?

Detalles Bibliográficos
Autor principal:	Westermark, Per
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Invited Speaker Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4642126/ http://dx.doi.org/10.1186/1750-1172-10-S1-I25

Ejemplares similares

Heart transplantation in hereditary ATTR amyloidosis
por: Slama, M
Publicado: (2015)

Do we need to demonstrate Amyloid in tissue?
por: Magy, Laurent
Publicado: (2015)

The landscape of treatment of chronic kidney disease in hereditary ATTR amyloidosis
por: Lobato, Luisa
Publicado: (2015)

Guidelines for genetic counselling in ATTR amyloidosis
por: Sequeiros, Jorge
Publicado: (2015)

Imaging cardiac ATTR amyloid
por: Hawkins, Philip N
Publicado: (2015)

Symptomatic therapy in ATTR amyloidosis: pain killers in TTR-FAP
por: Attal, Nadine
Publicado: (2015)

Ophtalmologic changes in transthyretin familial amyloid polyneuropathy (ATTR-FAP)
por: Ferreira, Natália
Publicado: (2015)

Positron Emission Tomography (PET) utilizing Pittsburgh compound B (PIB) detects amyloid heart deposits in hereditary transthyretin amyloidosis (ATTR).
por: Pilebro, Björn, et al.
Publicado: (2015)

ATTR-FAP: liver transplantation vs oral medication, how and when
por: Erikzon, Bo Goran
Publicado: (2015)

Cryo-EM structure of a transthyretin-derived amyloid fibril from a patient with hereditary ATTR amyloidosis
por: Schmidt, Matthias, et al.
Publicado: (2019)

Genome-forward oncology: how do we get there?
por: Ellis, Matthew
Publicado: (2011)

TTR amyloidosis: a scientific journey since Andrade
por: Saraiva, Maria João
Publicado: (2015)

Common transthyretin-derived amyloid fibril structures in patients with hereditary ATTR amyloidosis
por: Steinebrei, Maximilian, et al.
Publicado: (2023)

Patients with hereditary ATTR amyloidosis experience an increasing burden of illness as the disease progresses
por: Adams, David, et al.
Publicado: (2015)

Variation in amount of wild-type transthyretin in different fibril and tissue types in ATTR amyloidosis
por: Ihse, Elisabet, et al.
Publicado: (2010)

Treatment of gastrointestinal complication in transthyretin amyloidosis. A single centre’s experience
por: Suhr, Ole B
Publicado: (2015)

Quality of life in ATTR amyloidosis
por: Lane, Thirusha, et al.
Publicado: (2015)

New therapeutic perspectives – amyloid removal
por: Pepys, Mark
Publicado: (2015)

Headache research - where are we heading?
por: Jensen, Rigmor
Publicado: (2013)

Myths, need, contribution to the diagnosis
por: Bozzao, Alessandro
Publicado: (2015)

Early exposure hypothesis: where are we now?
por: Lack, Gideon
Publicado: (2011)

Genomics-based breeding in forest trees: are we there yet?
por: Neale, David
Publicado: (2011)

Quality of life assessment in amyloid transthyretin (ATTR) amyloidosis
por: Aimo, Alberto, et al.
Publicado: (2021)

Preliminary assessment of neuropathy progression in patients with hereditary ATTR amyloidosis after orthotopic liver transplantation (OLT)
por: Adams, David, et al.
Publicado: (2015)

Hereditary ATTR Amyloidosis in Austria: Prevalence and Epidemiological Hot Spots
por: Auer-Grumbach, Michaela, et al.
Publicado: (2020)

Practice of Hereditary ATTR Amyloidosis in Non-endemic Areas of Japan
por: Matsushima, Masaaki, et al.
Publicado: (2022)

Trials in rare diseases: the need to think differently
por: Billingham, Lucinda, et al.
Publicado: (2011)

Recruitment to trials - why is it hard and how might we make it less so?
por: Treweek, Shaun
Publicado: (2011)

PReS13-SPK-1582: Activity and damage - we have to measure them
por: Feldman, BM
Publicado: (2013)

PReS13-SPK-1028: Activity and damage - we have to measure them
por: Brunner, H
Publicado: (2013)

PReS13-SPK-1576: Unmeet needs in JIA treatment
por: Ruperto, N
Publicado: (2013)

Why do experts on ectodermal dysplasia (ED) meet again?
por: Bergendal, Birgitta
Publicado: (2012)

ATTR Amyloidosis: development of cardiac symptoms during 6 years of follow up in different ATTR-variants
por: Klaassen, Sebastiaan, et al.
Publicado: (2015)

Hydrocephalus treatment and outcome in African infants with myelomeningocele: what we have learned so far
por: Warf, Benjamin C
Publicado: (2010)

PReS13-SPK-1247: Activity and damage in juvenile systemic sclerosis- we have to measure them
por: Foeldvari, I
Publicado: (2013)

Amyloid Cardiomyopathy in Hereditary Transthyretin V30M Amyloidosis - Impact of Sex and Amyloid Fibril Composition
por: Arvidsson, Sandra, et al.
Publicado: (2015)

Tafamidis for autonomic neuropathy in hereditary transthyretin (ATTR) amyloidosis: a review
por: Cruz, Márcia Waddington
Publicado: (2019)

INSP-06. Recent advances in improving neuropsychological outcomes for paediatric brain tumour patients - Are we entering a new era?
por: Mabbott, Donald
Publicado: (2022)

Soft tissue handling and dental implant treatment
por: Neukam, Friedrich Wilhelm
Publicado: (2012)

Biotech Eucalyptus can sustainably address society’s need for wood: the example of freeze tolerant Eucalyptus in the southeastern U.S
por: Hinchee, Maud, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_60jo5r2jj4pvd4cfneqcfjbqt3